Article
Role of IL28B polymorphism in the development of hepatitis C virus-induced hepatocellular carcinoma, graft fibrosis, and posttransplant antiviral therapy.
Transplantation - 27 Mar 2012
Eurich Dennis, Boas-Knoop Sabine, Bahra Marcus, Neuhaus Ruth, Somasundaram Rajan, Neuhaus Peter, Neumann Ulf, Seehofer Daniel
Abstract excerpt
BACKGROUND: The development of liver graft disease is partially determined by individual genetic background. Interleukin 28B (IL28B) is strongly suspected to be involved in susceptibility for hepatitis C virus (HCV) infection, inflammation, and antiviral treatment response before and after liver transplantation (LT). Currently, the role of IL28B polymorphism (rs12979860) in the development of hepatocellular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
